Poyrazoğlu Sükran, Günöz Hülya, Darendeliler Feyza, Saka Nurçin, Bundak Rüveyde, Baş Firdevs
Department of Growth & Development and Pediatric Endocrinology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
J Pediatr Endocrinol Metab. 2005 Feb;18(2):171-9. doi: 10.1515/jpem.2005.18.2.171.
This retrospective study evaluated clinical characteristics of patients with constitutional delay of growth and puberty (CDGP) at presentation, during puberty and at final height. The records of 151 children (105 boys, 46 girls) with CDGP were reviewed and the results were evaluated with respect to findings in healthy Turkish schoolchildren. CDGP was twice as frequent in boys as in girls. Height and weight deficit and short sitting height of the children were evident at presentation and continued up to final height. Mean age of onset of puberty was retarded by 2.5 years in girls and by 3 years in boys. The time between onset of puberty and pubertal growth spurt was shorter in both girls and boys than in the controls. Peak growth velocity was compromised in both girls and boys. Forty-one patients (30 boys, 11 girls) reached final height (FH). Mean FH was shorter than both target height and predicted adult height. The Bayley-Pinneau method was found to be a better predictor of FH than either the Tanner-Whitehouse method or target height. FH also showed correlation with the father's height. There was no effect of testosterone treatment on final height. Height deficit at onset of puberty, shorter duration between onset of puberty and pubertal growth spurt, compromised peak growth velocity and short upper segment due to delayed puberty, are findings which may explain the decreased final height of children with CDGP.
这项回顾性研究评估了体质性生长和青春期发育延迟(CDGP)患者在初诊时、青春期期间及成年终身高时的临床特征。回顾了151例CDGP患儿(105例男孩,46例女孩)的记录,并对照健康土耳其学童的检查结果进行了评估。CDGP在男孩中的发生率是女孩的两倍。患儿的身高和体重不足以及坐高较短在初诊时即很明显,并持续至成年终身高。女孩青春期开始的平均年龄延迟2.5岁,男孩延迟3岁。女孩和男孩青春期开始至青春期生长突增的时间均短于对照组。女孩和男孩的峰值生长速度均受损。41例患者(30例男孩,11例女孩)达到了成年终身高(FH)。平均成年终身高低于靶身高和预测的成人身高。发现贝利-平诺方法比坦纳-怀特豪斯方法或靶身高能更好地预测成年终身高。成年终身高也与父亲身高相关。睾酮治疗对成年终身高无影响。青春期开始时的身高不足、青春期开始至青春期生长突增的时间较短、峰值生长速度受损以及青春期延迟导致的上段较短,这些发现可能解释了CDGP患儿成年终身高降低的原因。